[Metabolic bone diseases : what's new in 2023]

Serge Ferrari1, Andrea Trombetti1, Anne-Cecile Debrach1

  • 1Service des maladies osseuses, Département de médecine, Hôpitaux universitaires de Genève, 1211 Genève 14.

Revue Medicale Suisse
|February 1, 2024
PubMed

Insights

This review explores osteoporosis treatments, comparing anabolic and anti-resorptive drugs for fracture reduction. It also highlights advancements in predicting fracture risk and treating rare bone diseases.

Area of Science:

  • Endocrinology and Bone Metabolism
  • Pharmacology of Bone Therapeutics
  • Clinical Osteoporosis Management

Context:

  • Real-world data on sequential romosozumab and denosumab therapy for osteoporosis.
  • Extensive review of the mechanisms underlying post-denosumab rebound.
  • Evaluation of current fracture risk prediction tools and emerging therapeutic strategies.

Purpose:

  • To synthesize current evidence on osteoporosis treatment efficacy and safety.
  • To elucidate the pathophysiology of bone density changes after antiresorptive therapy cessation.
  • To assess the comparative effectiveness of different drug classes and novel agents.

Summary:

  • Network meta-analysis confirms anabolic agents outperform anti-resorptives in reducing fractures.
  • Large-scale study indicates anti-resorptives reduce mortality.
  • FRAXPlus improves fracture risk prediction; Vitamin D benefits confirmed for fractures and falls.
  • Promising results from trials of new molecules for rare bone diseases like osteogenesis imperfecta.

Impact:

  • Informs clinical decision-making for osteoporosis management strategies.
  • Provides insights into managing treatment transitions and potential bone loss.
  • Advances understanding and treatment of complex bone disorders.
  • Enhances patient outcomes through improved fracture prevention and disease management.

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.3K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.7K
Essential Minerals for Bone Health01:31

Essential Minerals for Bone Health

The minerals contained in all of the food we consume are essential for our organ systems. However, certain essential minerals, such as calcium, phosphorus, magnesium, manganese, and fluoride, largely affect bone health.
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
3.9K